RN7SL629P

Across TCGA pan-cancer cohorts, RN7SL629P RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of RN7SL629P’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where RN7SL629P RNA is repressed in tumor relative to normal tissue. In most cancer types RN7SL629P is over-expressed in tumor, although a few such as LUSC and BRCA show the opposite, repressed pattern.

LUSC, BRCA, and THCA are the cancer types where RN7SL629P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL629P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	All	−0.124	<.001	6	view →
BRCA	All	III,IV	−0.158	<.001	2	view →
THCA	All	All	−0.079	.004	2	view →
KIRC	All	All	+0.072	.004	2	view →
KIRP	Male	All	−0.058	.033	1	view →
COAD	Female	All	−0.056	.048	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

RN7SL629P–LUSC

Open the LUSC breakdown →